SCHEMBL6900402

SCHEMBL6900402

CNCCC(c1ccccc1)c1cccc(F)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.70
HRH1 P35367 2/20 0.70
SLC6A4 P31645 10/20 0.61
SLC6A2 P23975 7/20 0.54
SLC6A3 Q01959 2/20 0.54
TAAR1 Q96RJ0 1/20 0.49
KCNH2 Q12809 2/20 0.46
CYP2D6 P10635 2/20 0.46
CHRM2 P08172 1/20 0.46
HTR1A P08908 1/20 0.46
ADRA2A P08913 1/20 0.46
ADORA3 P0DMS8 1/20 0.46
CHRM1 P11229 1/20 0.46
SMPD1 P17405 1/20 0.46
DRD1 P21728 1/20 0.46
TBXA2R P21731 1/20 0.46
ADRA1A P35348 1/20 0.46
OPRM1 P35372 1/20 0.46
DRD3 P35462 1/20 0.46
CASR P41180 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Delucemine SCHEMBL678708 0.97 HTR2A (0.63) HTR2AHRH1SLC6A4SLC6A2SLC6A3
Delucemine SCHEMBL1661363 0.95 HTR2A (0.61) HTR2AHRH1SLC6A4SLC6A2SLC6A3
Delucemine SCHEMBL1649904 0.93 HTR2A (0.59) HTR2AHRH1SLC6A4SLC6A2SLC6A3
SCHEMBL14415637 0.85 SLC6A4 (0.60) HTR2AHRH1SLC6A4SLC6A2CYP2D6
SCHEMBL14415664 0.84 SLC6A4 (0.49) HTR2AHRH1SLC6A4SLC6A2SLC6A3
SCHEMBL3638413 0.84 HTR2A (1.00) HTR2AHRH1SLC6A4SLC6A2SLC6A3
SCHEMBL14415663 0.82 SLC6A4 (0.50) HTR2AHRH1SLC6A4SLC6A2SLC6A3
Hydrochloric Acid SCHEMBL5223012 0.82 HTR2A (0.95) HTR2AHRH1SLC6A4SLC6A2SLC6A3
SCHEMBL14415613 0.81 SLC6A4 (0.70) HTR2AHRH1SLC6A4SLC6A2SLC6A3
SCHEMBL6050357 0.80 SLC6A4 (0.54) HTR2AHRH1SLC6A4SLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7268166-B2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases NPS PHARMACEUTICALS, INC. (US) 2007-09-11 US disclosed
US-7268166-B2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases NPS PHARMACEUTICALS, INC. (US) 2007-09-11 US disclosed
EP-1096926-B1 METHODS AND COMPOUNDS FOR TREATING DEPRESSION NPS PHARMA INC (US) 2007-02-28 EP disclosed
US-6750244-B2 NERVOUS SYSTEM DISORDERS NPS PHARMACEUTICALS, INC. 2004-06-15 US disclosed
US-6211245-B1 DRUGS FOR CONTROLLING CALCIUM MODULATORS NPS PHARMACEUTICALS, INC. 2001-04-03 US disclosed